Myriad Asset Management Advisors LLC Invests $4.86 Million in SPDR S&P Biotech ETF $XBI

Myriad Asset Management Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 39,864 shares of the exchange traded fund’s stock, valued at approximately $4,861,000. SPDR S&P Biotech ETF accounts for approximately 1.5% of Myriad Asset Management Advisors LLC’s portfolio, making the stock its 16th biggest holding.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the period. Bessemer Group Inc. boosted its stake in SPDR S&P Biotech ETF by 13.5% in the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after purchasing an additional 220,244 shares during the period. Ameriprise Financial Inc. boosted its stake in SPDR S&P Biotech ETF by 40.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after purchasing an additional 353,351 shares during the period. LPL Financial LLC boosted its stake in SPDR S&P Biotech ETF by 27.0% in the 4th quarter. LPL Financial LLC now owns 875,547 shares of the exchange traded fund’s stock worth $106,755,000 after purchasing an additional 185,964 shares during the period. Finally, Greenhouse Funds LLLP boosted its stake in SPDR S&P Biotech ETF by 16.6% in the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after purchasing an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.9%

Shares of NYSEARCA XBI opened at $128.85 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $80.90 and a 52 week high of $139.19. The business has a 50-day simple moving average of $132.43 and a two-hundred day simple moving average of $126.96. The company has a market cap of $8.22 billion, a P/E ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.